Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study

Steroid‐refractory chronic graft‐vs‐host disease (cGvHD) contributes to morbidity after allogeneic hematopoietic stem cell transplantation. Here, we report on 11 patients with severe, refractory cGvHD treated with repeated infusions of allogeneic bone marrow‐derived mesenchymal stromal cells (MSC) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Boberg, Erik, von Bahr, Lena, Afram, Gabriel, Lindström, Carina, Ljungman, Per, Heldring, Nina, Petzelbauer, Peter, Garming Legert, Karin, Kadri, Nadir, Le Blanc, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Cell‐based Drug Development, Screening, and Toxicology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519760/
https://www.ncbi.nlm.nih.gov/pubmed/32573983
http://dx.doi.org/10.1002/sctm.20-0099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519760/
https://www.ncbi.nlm.nih.gov/pubmed/32573983
http://dx.doi.org/10.1002/sctm.20-0099

Ejemplares similares